Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Miele

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
Cancers|January 11, 2022
A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular CarcinomaKrizia Pocino, Cecilia Napodano, Mariapaola Marino, et al.
Journal of Clinical Gastroenterology|June 20, 2007
Role of the "immersion technique" in diagnosing celiac disease with villous atrophy limited to the duodenal bulbGiovanni Cammarota, Paola Cesaro, Rossella La Mura, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 17, 2024
Serum-free light chains as a dependable biomarker for stratifying patients with metabolic dysfunction-associated steatotic liver diseaseAntonio Liguori, Francesca D'Ambrosio, Cecilia Napodano, et al.
BMC Public Health|September 27, 2006
Correlates of HCV seropositivity among familial contacts of HCV positive patientsGiuseppe La Torre, Luca Miele, Alice Mannocci, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 10, 2020
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of plateletsLuca Miele, Maria Adele Alberelli, Maurizio Martini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 13, 2016
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disordersFrancesca Gulli, Umberto Basile, Laura Gragnani, et al.
Clinical Epigenetics|August 22, 2020
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD)Diana Buzova, Andrea Maugeri, Antonio Liguori, et al.
Gastroenterology Report|April 26, 2024
A novel <i>ABCB11</i> variant in compound heterozygosity: BRIC2 or PFIC2?Marco Biolato, Rosy Terranova, Nicholas Viceconti, et al.
Biomolecules|June 26, 2026
Emerging Therapeutic Perspectives in Obese Patients with MASLD Leading to Compensated Advanced Chronic Liver DiseaseRoberta Chianetta, Lydia Giannitrapani, Alessio Giuseppe Lipari, et al.
Frontiers in Neurology|June 30, 2020
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional StudyAlessia Perna, Daria Maccora, Salvatore Rossi, et al.
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
Cancers|January 11, 2022
A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular CarcinomaKrizia Pocino, Cecilia Napodano, Mariapaola Marino, et al.
Journal of Clinical Gastroenterology|June 20, 2007
Role of the "immersion technique" in diagnosing celiac disease with villous atrophy limited to the duodenal bulbGiovanni Cammarota, Paola Cesaro, Rossella La Mura, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 17, 2024
Serum-free light chains as a dependable biomarker for stratifying patients with metabolic dysfunction-associated steatotic liver diseaseAntonio Liguori, Francesca D'Ambrosio, Cecilia Napodano, et al.
BMC Public Health|September 27, 2006
Correlates of HCV seropositivity among familial contacts of HCV positive patientsGiuseppe La Torre, Luca Miele, Alice Mannocci, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 10, 2020
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of plateletsLuca Miele, Maria Adele Alberelli, Maurizio Martini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 13, 2016
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disordersFrancesca Gulli, Umberto Basile, Laura Gragnani, et al.
Clinical Epigenetics|August 22, 2020
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD)Diana Buzova, Andrea Maugeri, Antonio Liguori, et al.
Gastroenterology Report|April 26, 2024
A novel <i>ABCB11</i> variant in compound heterozygosity: BRIC2 or PFIC2?Marco Biolato, Rosy Terranova, Nicholas Viceconti, et al.
Biomolecules|June 26, 2026
Emerging Therapeutic Perspectives in Obese Patients with MASLD Leading to Compensated Advanced Chronic Liver DiseaseRoberta Chianetta, Lydia Giannitrapani, Alessio Giuseppe Lipari, et al.
Frontiers in Neurology|June 30, 2020
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional StudyAlessia Perna, Daria Maccora, Salvatore Rossi, et al.
Pageof 18